JPMorgan raised the firm’s price target on Oxford Biomedica (OXBDF) to 450 GBp from 305 GBp and keeps a Neutral rating on the shares.
JPMorgan raised the firm’s price target on Oxford Biomedica (OXBDF) to 450 GBp from 305 GBp and keeps a Neutral rating on the shares.